SRS Capital Advisors »

Atea Pharmaceuticals shares owned by SRS Capital Advisors

Quarter-by-quarter ownership of Atea Pharmaceuticals (AVIR) shares owned by SRS Capital Advisors from 13F filings

Historical chart of SRS Capital Advisors investment in Atea Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Atea Pharmaceuticals held by SRS Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atea Pharmaceuticals by SRS Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $577 199 2.90

More positions owned by SRS Capital Advisors

Vanguard Index Fds Growth Etf (VOO)
Ishares Tr Ishs 1-5yr Invs (OEF)
First Tr Exchange-traded Wtr Etf (FDL)
American Centy Etf Tr Us Large Cap Vlu (KORP)
Dimensional Etf Trust Intl Core Equity (DFAI)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
Schwab Strategic Tr Us Tips Etf (SCHB)
Microsoft Corporation (MSFT)
First Tr Exchng Traded Fd Vi Smith Opport Fxd (FIXD)
First Tr Exchange Traded Risng Divd Achiv (FXN)
NVIDIA Corporation (NVDA)
First Tr Exch Traded Fd Iii Pfd Secs Inc Etf (FPE)
Spdr S&p 500 Etf Tr Tr Unit
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)

View all positions for SRS Capital Advisors

Top funds holding Atea Pharmaceuticals

BlackRock
BML Capital Management
FMR
Tang Capital Management
Vanguard Group
Bain Capital Life Sciences Investors
Geode Capital Management
State Street Corporation
Dimensional Fund Advisors
Renaissance Technologies
Acadian Asset Management
Two Sigma Advisers
Northern Trust
Charles Schwab Investment Management
Jpmorgan Chase & Co

View all funds holding Atea Pharmaceuticals